Recruiting
The Cohort Study for Asthma in China
The study is to establish a standardized asthma cohort study, build an information network platform system and a biospecimen bank for asthma cohort, establish clear follow-up standards and norms, observe the asthma outcomes and identify biomarkers to predict asthma outcomes.
ClinicalTrials.gov IDNCT05937334
PhaseNot Applicable
Enrollment400
SponsorBeijing Chao Yang Hospital
Age18 Years and older
SexALL
Conditions studied
Asthma, Bronchial
About this study
The study is to establish a standardized asthma cohort study, build an information network platform system and a biospecimen bank for asthma cohort, establish clear follow-up standards and norms, observe the asthma outcomes and identify biomarkers to predict asthma outcomes.
Interventions
- Diagnostic Test: Diagnostic Test: lung function test, chest CT, induced sputum, blood routine test, IgE test, FeNO test, six minutes walk test, questionnaires for asthma — lung function test, chest CT, induced sputum, blood routine test, IgE test, FeNO test, six minutes walk test, questionnaires for asthma were performed. All interventions was made according to routine diagnosis and treatment.
Primary outcomes
- Asthma Control Test(ACT) (2 years)
- Asthma Control Questionnaire(ACQ) (2 years)
- Induced sputum analysis (2 years)
Eligibility information
Inclusion Criteria:
* Age \>18
* Meet the 2023 edition of GINA asthma diagnostic criteria
* Subjects must sign informed consent prior to study participation, participate in the study according to the protocol and follow up for 2 years
Exclusion Criteria:
* Suffering from other massive lung tissue destructive diseases such as severe bronchiectasis and tuberculosis
* Severe pleural disease and/or sternal and rib lesions
* Serious uncontrolled disease of other system
* Thoracic or abdominal surgery in the past 3 months
* Eye surgery in the past three months
* Retina detachment
* Myocardial infarction within the last 3 months
* Hospitalized for heart disease within the past 3 months
* Ongoing anti-tuberculosis treatment
* Pregnancy or breast feeding
Study locations
- Beijing Chao Yang Hospital, Beijing, Beijing Municipality China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-05.